E75a Special Niches: Bone

Topic

As a tumor niche, bone is characterized primarily by a mineralized extracellular matrix—composed mainly of minerals—that possesses extreme rigidity, far exceeding that of any other soft tissue in the body. This extreme stiffness generates bone-specific mechanical signals that the tissue itself converts into biological signals: on one hand, via integrins (anchoring molecules connecting the cell to the surrounding matrix) and, on the other, through bone piezoelectricity—the tissue's inherent ability to generate a small electric current when mechanically deformed.

The central physical process occurring when a tumor establishes itself in bone is known as the "vicious cycle" of bone destruction. This cycle begins when the tumor releases a signaling molecule that directly activates osteoclasts—specialized bone cells responsible for destroying and resorbing mineralized bone tissue.

Upon activation, osteoclasts carry out bone resorption—destroying and dissolving the mineral bone matrix—and in doing so, release a growth factor that had previously been trapped within that matrix.

This released growth factor stimulates the proliferation of the tumor cells themselves; this increase in tumor cells leads to the release of even more of the signaling molecule that activates osteoclasts, thereby closing the vicious cycle of bone destruction: more tumor activates more osteoclasts, more osteoclasts destroy more bone, and more destroyed bone releases more growth factor, fueling an even larger tumor. In addition to this vicious cycle of bone destruction, there is a second physical mechanism explaining why certain tumors preferentially colonize bone: the bone's vascular architecture includes specialized blood vessels in the bone marrow known as sinusoids, and bone marrow support cells release a signaling molecule that specifically attracts tumor cells bearing the corresponding receptor on their surface. Both prostate cancer cells and myeloma cells express this receptor at particularly high levels, explaining the selective tropism of both tumors for bone tissue via these marrow sinusoids.

It is this vicious cycle of bone destruction—combined with the selective bone tropism driven by the bone's vascular architecture in the case of tumors such as prostate cancer and myeloma—that explains why bone metastases, once established, tend to grow in a self-perpetuating manner. Consequently, treatment strategies often aim specifically to interrupt this cycle (for instance, by blocking osteoclast activation) in order to halt both bone destruction and the tumor growth fueled by that cycle.

ID:4239